Overall rank by patents
#3,052
Across all tracked assignees
USPTO PatentsView assignee record - 125 granted patents across 100 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61P (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS).
The verdict
Université holds 125 US patents across 100 technology areas, rank #3,052 of 50,000 tracked assignees.
Université Laval has been granted 125 US utility patents between 2015 and 2025, placing Université Laval at rank #3,052 across all assignees tracked by PlainPatent. This portfolio spans 100 distinct Cooperative Patent Classification (CPC) subclasses, averaging 16.2 claims per patent with primary concentration in A61P (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS). As a Foreign Corporation, Université Laval is one of the broader-portfolio assignees in the PatentsView dataset. By volume, Université sits between SKC Co., Ltd. (125 patents, rank #3,048) and Acceleron Pharma Inc. (124 patents, rank #3,056) - the closest US assignees by grant volume. The composite Innovation Score of 57.0/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 64 grants, compared with 61 in the 2015–2019 window, a +5% shift in five-year velocity. Steady filing volume suggests sustained innovation without dramatic pivots. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Université Laval's 16.2 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a diversified footprint across 100+ CPC subclasses spreads risk across many technology fronts. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Université Laval against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
SKC CO., LTD.
125 patents
SimpliSafe, Inc.
125 patents
Stichting IMEC Nederland
125 patents
UCL Business Ltd
125 patents
V-NOVA INTERNATIONAL LIMITED
125 patents
Wm. Wrigley Jr. Company
125 patents
Université Laval
125 patents
ASM TECHNOLOGY SINGAPORE PTE LTD
124 patents
Acceleron Pharma Inc.
124 patents
What this shows Université holds 125 patents at rank #3,052, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #3,052 in granted patent volume.
Other assignees with the most granted patents in Université's primary technology class.
Université's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
57 Top 6% higher than 94% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 6 | 4.8% |
| 2016 | 10 | 8.0% |
| 2017 | 18 | 14.4% |
| 2018 | 14 | 11.2% |
| 2019 | 13 | 10.4% |
| 2020 | 13 | 10.4% |
| 2021 | 9 | 7.2% |
| 2022 | 14 | 11.2% |
| 2023 | 4 | 3.2% |
| 2024 | 11 | 8.8% |
| 2025 | 13 | 10.4% |
Top 15 of 100 technology areas
Overall rank by patents
#3,052
Across all tracked assignees
57.0 out of 100
How to use this portfolio
Université's 125 grants land it in the top 6% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.